Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease.

  • Read more about Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease.

Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy.

  • Read more about Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy.

The Digital Determinants of Liver Disease.

  • Read more about The Digital Determinants of Liver Disease.

Racial/Ethnic Disparities in Wait List Outcomes Are Only Partly Explained by Socioeconomic Deprivation Among Children Awaiting Liver Transplantation.

  • Read more about Racial/Ethnic Disparities in Wait List Outcomes Are Only Partly Explained by Socioeconomic Deprivation Among Children Awaiting Liver Transplantation.

Addressing social adversity to improve outcomes for children after liver transplant.

  • Read more about Addressing social adversity to improve outcomes for children after liver transplant.

Recurrence of primary sclerosing cholangitis after liver transplant in children: an international observational study.

  • Read more about Recurrence of primary sclerosing cholangitis after liver transplant in children: an international observational study.

Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.

  • Read more about Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.

Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency.

  • Read more about Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency.

Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.

  • Read more about Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.

To Juice or Not to Juice: Fatty Liver Repercussions for Infants.

  • Read more about To Juice or Not to Juice: Fatty Liver Repercussions for Infants.

Pagination

  • Page 1
  • Next page ››
Subscribe to Hepatology (Baltimore, Md.)

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List